Retatrutide
CAS No.2381089-83-2
Triple agonist: GLP-1R / GIPR / GCGR
Obesity, metabolic diseases
Survodutide
CAS No.2805997-46-8
Dual agonist: GCGR + GLP-1R
Obesity, MASH/NASH
Orforglipron
CAS No.2212020-52-3
Oral small-molecule GLP-1 receptor agonist
Obesity, type 2 diabetes
Inclisiran
CAS No.1639324-58-5
siRNA targeting PCSK9 mRNA
Hypercholesterolemia, ASCVD risk reduction
Cagrilintide
CAS No.1415456-99-3
Amylin analogue / amylin receptor agonist
Obesity; combination therapy with semaglutide (CagriSema)
Elamipretide
CAS No.736992-21-5
Mitochondria-targeted peptide binding cardiolipin
Barth syndrome; mitochondrial diseases
Glepaglutide
CAS No.914009-86-2
GLP-2 receptor agonist
Short bowel syndrome